Evidenced-based clinical practice guideline for upper tract urothelial carcinoma (summary - Japanese Urological Association, 2014 edition)

the Committee for Establishment of the Clinical Practice Guideline for the Management of Upper Tract Urothelial Carcinoma and the Japanese Urological Association

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Upper tract urothelial carcinoma is more rare than bladder cancer, although they are both categorized as urothelial carcinoma. Because of the low incidence, little clinical evidence is available regarding the treatment of the former. However, recently such evidence has slowly begun to accumulate. The guideline presented herein was compiled for the purpose of ensuring proper diagnosis and treatment by physicians involved in the treatment of upper tract urothelial carcinoma. We carefully selected 16 clinical questions essential for daily clinical practice and grouped them into four major categories: epidemiology, diagnosis, surgery and systemic chemotherapy/other matters. Related literature was searched using PubMed and Japan Medical Abstracts Society databases for articles published between 1987 and 2013. If the judgment was made on the basis of insufficient or inadequate evidence, the grade of recommendation was determined on the basis of committee discussions and resultant consensus statements. Here, we present a short English version of the original guideline, and overview its key clinical issues.

Original languageEnglish
Pages (from-to)3-13
Number of pages11
JournalInternational Journal of Urology
Volume22
Issue number1
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Practice Guidelines
Carcinoma
Guidelines
Medical Societies
PubMed
Urinary Bladder Neoplasms
Consensus
Japan
Epidemiology
Therapeutics
Databases
Physicians
Drug Therapy
Incidence

Keywords

  • Guideline
  • Renal pelvic tumor
  • Upper tract urothelial carcinoma
  • Ureteral tumor

ASJC Scopus subject areas

  • Urology

Cite this

the Committee for Establishment of the Clinical Practice Guideline for the Management of Upper Tract Urothelial Carcinoma and the Japanese Urological Association (2015). Evidenced-based clinical practice guideline for upper tract urothelial carcinoma (summary - Japanese Urological Association, 2014 edition). International Journal of Urology, 22(1), 3-13. https://doi.org/10.1111/iju.12630

Evidenced-based clinical practice guideline for upper tract urothelial carcinoma (summary - Japanese Urological Association, 2014 edition). / the Committee for Establishment of the Clinical Practice Guideline for the Management of Upper Tract Urothelial Carcinoma and the Japanese Urological Association.

In: International Journal of Urology, Vol. 22, No. 1, 01.01.2015, p. 3-13.

Research output: Contribution to journalArticle

the Committee for Establishment of the Clinical Practice Guideline for the Management of Upper Tract Urothelial Carcinoma and the Japanese Urological Association 2015, 'Evidenced-based clinical practice guideline for upper tract urothelial carcinoma (summary - Japanese Urological Association, 2014 edition)', International Journal of Urology, vol. 22, no. 1, pp. 3-13. https://doi.org/10.1111/iju.12630
the Committee for Establishment of the Clinical Practice Guideline for the Management of Upper Tract Urothelial Carcinoma and the Japanese Urological Association. Evidenced-based clinical practice guideline for upper tract urothelial carcinoma (summary - Japanese Urological Association, 2014 edition). International Journal of Urology. 2015 Jan 1;22(1):3-13. https://doi.org/10.1111/iju.12630
the Committee for Establishment of the Clinical Practice Guideline for the Management of Upper Tract Urothelial Carcinoma and the Japanese Urological Association. / Evidenced-based clinical practice guideline for upper tract urothelial carcinoma (summary - Japanese Urological Association, 2014 edition). In: International Journal of Urology. 2015 ; Vol. 22, No. 1. pp. 3-13.
@article{816c38b88e9b4f8a8db1a5071a4285f2,
title = "Evidenced-based clinical practice guideline for upper tract urothelial carcinoma (summary - Japanese Urological Association, 2014 edition)",
abstract = "Upper tract urothelial carcinoma is more rare than bladder cancer, although they are both categorized as urothelial carcinoma. Because of the low incidence, little clinical evidence is available regarding the treatment of the former. However, recently such evidence has slowly begun to accumulate. The guideline presented herein was compiled for the purpose of ensuring proper diagnosis and treatment by physicians involved in the treatment of upper tract urothelial carcinoma. We carefully selected 16 clinical questions essential for daily clinical practice and grouped them into four major categories: epidemiology, diagnosis, surgery and systemic chemotherapy/other matters. Related literature was searched using PubMed and Japan Medical Abstracts Society databases for articles published between 1987 and 2013. If the judgment was made on the basis of insufficient or inadequate evidence, the grade of recommendation was determined on the basis of committee discussions and resultant consensus statements. Here, we present a short English version of the original guideline, and overview its key clinical issues.",
keywords = "Guideline, Renal pelvic tumor, Upper tract urothelial carcinoma, Ureteral tumor",
author = "{the Committee for Establishment of the Clinical Practice Guideline for the Management of Upper Tract Urothelial Carcinoma and the Japanese Urological Association} and Mototsugu Oya and Eiji Kikuchi",
year = "2015",
month = "1",
day = "1",
doi = "10.1111/iju.12630",
language = "English",
volume = "22",
pages = "3--13",
journal = "International Journal of Urology",
issn = "0919-8172",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Evidenced-based clinical practice guideline for upper tract urothelial carcinoma (summary - Japanese Urological Association, 2014 edition)

AU - the Committee for Establishment of the Clinical Practice Guideline for the Management of Upper Tract Urothelial Carcinoma and the Japanese Urological Association

AU - Oya, Mototsugu

AU - Kikuchi, Eiji

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Upper tract urothelial carcinoma is more rare than bladder cancer, although they are both categorized as urothelial carcinoma. Because of the low incidence, little clinical evidence is available regarding the treatment of the former. However, recently such evidence has slowly begun to accumulate. The guideline presented herein was compiled for the purpose of ensuring proper diagnosis and treatment by physicians involved in the treatment of upper tract urothelial carcinoma. We carefully selected 16 clinical questions essential for daily clinical practice and grouped them into four major categories: epidemiology, diagnosis, surgery and systemic chemotherapy/other matters. Related literature was searched using PubMed and Japan Medical Abstracts Society databases for articles published between 1987 and 2013. If the judgment was made on the basis of insufficient or inadequate evidence, the grade of recommendation was determined on the basis of committee discussions and resultant consensus statements. Here, we present a short English version of the original guideline, and overview its key clinical issues.

AB - Upper tract urothelial carcinoma is more rare than bladder cancer, although they are both categorized as urothelial carcinoma. Because of the low incidence, little clinical evidence is available regarding the treatment of the former. However, recently such evidence has slowly begun to accumulate. The guideline presented herein was compiled for the purpose of ensuring proper diagnosis and treatment by physicians involved in the treatment of upper tract urothelial carcinoma. We carefully selected 16 clinical questions essential for daily clinical practice and grouped them into four major categories: epidemiology, diagnosis, surgery and systemic chemotherapy/other matters. Related literature was searched using PubMed and Japan Medical Abstracts Society databases for articles published between 1987 and 2013. If the judgment was made on the basis of insufficient or inadequate evidence, the grade of recommendation was determined on the basis of committee discussions and resultant consensus statements. Here, we present a short English version of the original guideline, and overview its key clinical issues.

KW - Guideline

KW - Renal pelvic tumor

KW - Upper tract urothelial carcinoma

KW - Ureteral tumor

UR - http://www.scopus.com/inward/record.url?scp=84920895447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920895447&partnerID=8YFLogxK

U2 - 10.1111/iju.12630

DO - 10.1111/iju.12630

M3 - Article

C2 - 25243652

AN - SCOPUS:84920895447

VL - 22

SP - 3

EP - 13

JO - International Journal of Urology

JF - International Journal of Urology

SN - 0919-8172

IS - 1

ER -